Who owns CASC - CASCADIAN THERAPEUTICS INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CASCADIAN THERAPEUTICS INC - COM (CASC) Institutional Ownership

Q: What is CUSIP 14740B101?

CUSIP 14740B101 is the security identifier used in SEC filing datasets for CASC - CASCADIAN THERAPEUTICS INC - COM.

CUSIP: 14740B101

13F Institutional Holders and Ownership History from Q2 2016 to Q1 2017

Type / Class: Equity / COM
Symbol: CASC

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 14740B101?
CUSIP 14740B101 identifies CASC - CASCADIAN THERAPEUTICS INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 14740B101:

Q1 2017 (0 holders) Q4 2016 (0 holders) Q3 2016 (69 holders) Q2 2016 (67 holders)

Institutional Holders of CASCADIAN THERAPEUTICS INC - COM (CASC) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2017 Q1	0	$0	-$2,799				0
2016 Q4	0	$0	-$140,884,019	$0	$0		0
2016 Q3	86,828,956	$142,391,799	-$2,859,431	$77,000	$25,000	$1.64	69
2016 Q2	89,396,217	$84,272,571	+$83,218,571	$50,000	$11,000	$0.94	67